Re: ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma

Affiliations

¹ Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
² Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: yair.lotan@utsouthwestern.edu.

Comment

Solomon L Woldu et al. Eur Urol. 2021 Oct.

. 2021 Oct;80(4):517-518.

doi: 10.1016/j.eururo.2021.07.018. Epub 2021 Aug 6.

¹ Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
² Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: yair.lotan@utsouthwestern.edu.

No abstract available

Comment on

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
Powles T, Assaf ZJ, Davarpanah N, Banchereau R, Szabados BE, Yuen KC, Grivas P, Hussain M, Oudard S, Gschwend JE, Albers P, Castellano D, Nishiyama H, Daneshmand S, Sharma S, Zimmermann BG, Sethi H, Aleshin A, Perdicchio M, Zhang J, Shames DS, Degaonkar V, Shen X, Carter C, Bais C, Bellmunt J, Mariathasan S. Powles T, et al. Nature. 2021 Jul;595(7867):432-437. doi: 10.1038/s41586-021-03642-9. Epub 2021 Jun 16. Nature. 2021. PMID: 34135506 Clinical Trial.